The present invention provides a hyperglycemic inhibitor having a serine protease inhibitory action, which is a novel prophylactic or therapeutic drug for diabetes. A compound represented by the following formula (I), wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof
-
Page/Page column 28
(2012/11/06)
More Articles about upstream products of 1311290-73-9